Quick Answer
IMMUCELL CORP /DE/ reported Net Income Loss of -$1.04 million for the year ending 2025.
- IMMUCELL CORP /DE/ showed an increase of +51.8% in Net Income Loss from 2024 to 2025.
- This data is from IMMUCELL CORP /DE/'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), IMMUCELL CORP /DE/'s Net Income Loss has declined by 380.4%.
- Historical annual values: Fiscal year 2025: -$1.04 million | Fiscal year 2024: -$2.16 million | Fiscal year 2023: -$5.77 million | Fiscal year 2022: -$2.49 million | Fiscal year 2021: -$78.3 thousand | Fiscal year 2020: -$1.02 million | Fiscal year 2019: -$1.30 million | Fiscal year 2018: -$2.32 million | Fiscal year 2017: -$168.1 thousand | Fiscal year 2016: $508.4 thousand | Fiscal year 2015: $1.21 million | Fiscal year 2014: -$167.2 thousand | Fiscal year 2013: $117.4 thousand | Fiscal year 2012: $89.5 thousand | Fiscal year 2011: -$409.5 thousand | Fiscal year 2010: -$384.7 thousand | Fiscal year 2009: -$216.5 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: